Treatment of Female Infertility

Yoo Shin Kim; Tae Ki Yoon

doi:10.5124/jkma.2007.50.5.406

Journal List > J Korean Med Assoc > v.50(5) > 1041895

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim and Yoon: Treatment of Female Infertility

Focused Issue of This Month

Infertility

Journal of the Korean Medical Association

Journal of the Korean Medical Association 2007; 50(5): 406-414.

Published online: 31 May 2007

DOI: https://doi.org/10.5124/jkma.2007.50.5.406

Treatment of Female Infertility

Yoo Shin Kim, MD, Tae Ki Yoon, MD

Department of Obstetrics and Gynecology, Pochon Cha University College of Medicine, Korea. medikys@cha.ac.kr, tkyoon@cha.ac.kr

Abstract

Infertility is a disease that exists when a couple has tried to conceive for 12 months during which time they have had intercourse without the use of contraception. There are many factors suggested as being the causative factors for this problem, and various diagnostic and therapeutic approaches are under practice to alleviate infertility with a great advancement in the molecular biology, cryobiology, assisted reproductive technologies (ART), etc. Earlier evaluation and treatment are required in women with age over 35 years and those with certain medical conditions. The couple should be evaluated at the same time. Stress, which can be manifested as anxiety or depression, is increased in women experiencing infertility. Therefore clinicians need to provide comprehensive care services that are individualized based on the patient's situation, including psychological support and counseling.

Keywords: Infertility, ART, Microsurgery

Figures and Tables

Figure 1

Diagnostic and Treatment Algorithm : Infertility.

Yao M. Clinical management of infertility. Washington DC: The Advisory Bord, 2000.

Table 1

Clinical findings that suggest Insulin Resistance and Hyperinsulinemia

Barbieri RL. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am J Obstet Gynecol 2000;183:1412-1418

References

1. ASRM practice committee and ethics committee. Fertil Steri. 2004. 82:S206.

2. Gysler M, March CM, Mishell DR Jr, Bailev EJ. A decade2s experience with individualized clomiphen treatment regimen including its effect on postcoital test. Fertil Steril. 1982. 37:161–167.

3. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphen citrate induction of ovulation. Obstet Gynecol. 1983. 62:196–202.

4. Shoham Z, Zosmer A, Insler V. Early miscarriage and fetal malformation after induction of ovulation (by clomiphen citrate and/or human menotropins), in vitro fertilization, and gamate intrafallopian transfer. Fertil Steril. 1991. 55:1–11.

5. Fisch P, Casper RF, Brown SE, Wrixon W, Collins JA, Reid RL, Simpson C. Unexplained infertility: evaluation of treatment with clomiphene citrate and human chorionic gonadotropin. Fertil Steril. 1989. 51:828–833.

6. Deaton JL, Gibson M, Blackmer K, Nakajima ST, Badger GJ, Brumsted JR. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril. 1990. 54:1083–1088.

7. Guzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP. Efficacy of treatment for unexplained infertility. Fertil Steril. 1998. 70:207–213.

8. Barbieri RL. The initial fertility consultation: recommendations concerning cigarette smoking, body mass index, and alcohol and caffeine consumption. Am J Obstet Gynecol. 2001. 185:1168–1173.

9. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidem. 1994. 5:247–250.

10. Clark AM, Thornely B, Tomlinson L, et al. Weight loss in obes infertile women result in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998. 13:1502–1505.

11. Clark AM, Roberts B, Galletley C, Tomlinson L, Normnn RJ. Maximizing weight loss in the overweight infertile patient-a prospective randomized controlled trial. Hum Reprod. 2000. 15:65–66.

12. Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steil. 2003. 79:1–13.

13. Kumari AS. Metformin monotherapy in lean women with polycystic ovary syndrome. RBM online. 2005. 10:100–104.

14. Kim LH, Taylor AE, Barbieri RL. Insulin sensitizers and polycystic ovary syndrome: can a diabetes medication treat infertility? Fertil Steril. 2000. 73:1097–1098.

15. Surrey ES, Schoolcraft WB. Laparoscopic management of Hyrosalpinges before in vitro fertilization embryo transfer: salpingectomy versus proximal tubal occlusion. Fertil Steril. 2001. 75:612–617.

16. Benadiva CA, Kligman I, Davis O, Rosenwaks Z. In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Fertil Steril. 1995. 64:1051–1061.

17. Osuna C, Matorras R, Pijoan JI, Rodriquiz-Escudero FJ. One versus two inseminations per cycle in intrauterine insemination with sperm from patients' husband: a systemic review of the literature. Fertil Steril. 2004. 82:17–24.

18. Chafkin LM, Nulsen JC, Luciano AA, Metger DA. A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin(hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone. Fertil Steril. 1991. 55:252–257.

19. Aboulghar MA, Mansour RT, Serour GI, Rhodes CA, Amin YM. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation. J Assist Reprod Genet. 2000. 17:298–301.

20. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilizationin idiopathic subfertility and male subfertility: a randomized trial and cost-effectiveness analysis. Lancet. 2000. 355:13–18.

21. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992. 19:185–192.

22. Lundorff P, Hahlin M, Kallfelt B, Thorburn J, Lindblom B. Adhesion formation after laparoscpic surgery in tubal pregnancy: a randomized trial versus laparotomy. Fertil Steril. 1991. 55:911–915.

23. Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberqer L. Hyrosalpinx and IVF outcome: a prospective, randomized multicenter trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999. 14:2762–2769.

24. Surrey ES, Schoolcraft WB. Laparoscopic management of Hyrosalpinges before in vitro fertilization embryo transfer: salpingectomy versus proximal tubal occlusion. Fertil Steril. 2001. 75:612–617.

25. Benadiva CA, Kligman I, Davis O, Rosenwaks Z. In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Fertil Steril. 1995. 64:1051–1061.

26. Counsellor VS. Endometriosis. A clinical and surgical review. Am J Obstet Gynecol. 1938. 36:877.

27. TK Yoon, HR Sung, HG Kang, Cha SH, Lee CN, Cha KY. Laparoscopic tubal anastomosis: fertility outcome in 202 cases. Fertilty Steril. 1999. 72:1121–1126.

28. Falcone T, Goldberg JM, Margossian H, Stevens L. Robotic-assisted laparoscopic tubal anastomosis: a human pilot study. Fertilty Steril. 2000. 73:1040–1042.

29. Yoon TK, Lee DR, Cha SK, Chung HM, Lee WS, Cha KY. Surviaval rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologies. Fertil Steril. 2007. in press.

30. Lee WS. Current concept of infertility treatment. Korean Journal of Obstetrics and Gynecology. 2005. 48(5):1106–1129.

TOOLS

Similar articles